OpenSAFELY Vaccine Coverage Report
AstraZeneca / Priority Group 5
Data from combined, up to 2021-03-20.
| Vaccinated at 2021-03-20 (%) | Vaccinated at 2021-03-20 (n) | Population | Vaccinated at 2021-03-13 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 59.7% | 1,475,936 | 2,473,177 | 58.6% | 1.1% |
| Sex | Female | 59.6% | 751,415 | 1,261,750 | 58.6% | 1.0% |
| Male | 59.8% | 724,521 | 1,211,427 | 58.7% | 1.1% | |
| Ethnicity | White - British | 62.4% | 904,407 | 1,448,426 | 61.5% | 1.0% |
| White - Irish | 56.7% | 8,848 | 15,617 | 55.8% | 0.9% | |
| White - Any other White background | 44.0% | 34,867 | 79,205 | 43.0% | 1.1% | |
| Mixed - White and Black Caribbean | 42.2% | 1,337 | 3,171 | 40.2% | 2.0% | |
| Mixed - White and Black African | 41.7% | 1,071 | 2,569 | 40.6% | 1.1% | |
| Mixed - White and Asian | 53.4% | 1,365 | 2,555 | 52.3% | 1.1% | |
| Mixed - Any other mixed background | 47.2% | 2,331 | 4,942 | 45.8% | 1.4% | |
| Asian or Asian British - Indian | 53.6% | 26,985 | 50,323 | 52.8% | 0.8% | |
| Asian or Asian British - Pakistani | 47.0% | 11,732 | 24,983 | 45.2% | 1.8% | |
| Asian or Asian British - Bangladeshi | 54.9% | 3,395 | 6,188 | 52.8% | 2.0% | |
| Asian or Asian British - Any other Asian background | 49.4% | 11,088 | 22,428 | 48.3% | 1.2% | |
| Black or Black British - Caribbean | 39.4% | 5,901 | 14,959 | 37.3% | 2.1% | |
| Black or Black British - African | 40.0% | 6,097 | 15,260 | 37.9% | 2.1% | |
| Black or Black British - Any other Black background | 42.7% | 1,554 | 3,640 | 41.2% | 1.5% | |
| Other ethnic groups - Chinese | 48.5% | 4,564 | 9,415 | 47.1% | 1.3% | |
| Other ethnic groups - Any other ethnic group | 43.5% | 5,768 | 13,265 | 42.2% | 1.3% | |
| Patients with any other ethnicity code | 59.7% | 195,139 | 326,963 | 58.6% | 1.1% | |
| Ethnicity not stated | 58.7% | 8,841 | 15,071 | 57.5% | 1.2% | |
| Ethnicity not recorded | 58.1% | 240,534 | 414,092 | 56.9% | 1.1% | |
| Ethnicity (broad categories) | White | 61.4% | 948,136 | 1,543,255 | 60.4% | 1.0% |
| Mixed | 46.2% | 6,125 | 13,258 | 44.7% | 1.5% | |
| South Asian | 51.2% | 53,221 | 103,936 | 50.0% | 1.2% | |
| Black | 40.0% | 13,559 | 33,873 | 38.0% | 2.0% | |
| Other | 45.6% | 10,346 | 22,680 | 44.3% | 1.3% | |
| Unknown | 58.8% | 444,528 | 756,140 | 57.7% | 1.1% | |
| Index of Multiple Deprivation | 1 (most deprived) | 54.1% | 199,556 | 368,557 | 52.5% | 1.7% |
| 2 | 57.4% | 254,016 | 442,575 | 56.1% | 1.3% | |
| 3 | 59.9% | 314,265 | 524,776 | 58.9% | 1.0% | |
| 4 | 61.7% | 340,242 | 551,684 | 60.8% | 0.9% | |
| 5 (least deprived) | 63.0% | 355,383 | 564,004 | 62.3% | 0.7% | |
| Unknown | 57.8% | 12,460 | 21,560 | 57.0% | 0.7% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 60.3% | 546,105 | 905,772 | 59.2% | 1.1% |
| Patients with Immunosuppression | 60.9% | 22,981 | 37,744 | 60.0% | 0.9% | |
| Patients with CKD | 60.7% | 71,008 | 116,942 | 59.7% | 1.0% | |
| Patients who have Chronic Respiratory Disease | 60.4% | 58,387 | 96,677 | 59.3% | 1.1% | |
| Patients with Diabetes | 59.6% | 193,844 | 325,444 | 58.5% | 1.1% | |
| Patients with Chronic Liver disease | 59.4% | 43,722 | 73,640 | 58.3% | 1.1% | |
| Patients with CNS Disease (including Stroke/TIA) | 61.4% | 83,006 | 135,184 | 60.2% | 1.2% | |
| Patients with Chronic heart disease | 60.9% | 228,690 | 375,557 | 59.8% | 1.0% | |
| Patients with Asplenia or Dysfunction of the Spleen | 62.3% | 8,827 | 14,168 | 61.5% | 0.8% | |
| Patients with Wider Learning Disability | 61.0% | 3,542 | 5,810 | 57.6% | 3.4% | |
| Patients with Severe Mental Health | 55.7% | 13,230 | 23,737 | 53.6% | 2.1% | |
| Other Groups | Patients with Morbid Obesity | 60.2% | 46,984 | 78,064 | 58.9% | 1.3% |
| Patients who are pregnant | 61.1% | 154 | 252 | 61.1% | 0.0% |